Jong-Ho Kim

Prof. Dr. Jong-Ho Kim

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2018 in Arthroscopy Techniques
Verified
Journal Article
Open access
YKYang‐Soo Kim
Yang‐Soo Kim
HLHyo‐Jin Lee
Hyo‐Jin Lee
IPIn Park
In Park
GSGwang Young Sung
Gwang Young Sung
DKDong‐Jin Kim
Dong‐Jin Kim
JKJong-Ho Kim
Jong-Ho Kim
Large to massive rotator cuff tears are challenging to repair, although there are several options for dealing with them. Among them, superior capsular reconstruction was recently introduced as an effective procedure for retaining the static stability of the shoulder joint and preventing the progression to cuff tear arthropathy. The purpose of this technique‐based article is to describe a surgical option, called arthroscopic in situ superior capsular reconstruction, for large to massive rotator cuff tears using the long head of the biceps tendon. Technique Video: video See video under supplementary data.

30 November 2023 in Diabetes & Metabolism Journal
Verified
Journal Article
Open access
PDF file
JKJong-Ho Kim
Jong-Ho Kim
BKBong-Seoung Kim
Bong-Seoung Kim
KHKyungdo Han
Kyungdo Han
HKHyuk-Sang Kwon
Hyuk-Sang Kwon
Background: This study aimed to investigate the association between type 2 diabetes mellitus (T2DM) and shoulder adhesive capsulitis (AC) using a large-scale, nationwide, population-based cohort in the Republic of Korea.Methods: A total of 3,471,745 subjects aged over 20 years who underwent a National Health Insurance Service medical checkup between 2009 and 2010 were included in this study, and followed from the date of their medical checkup to the end of 2018. Subjects were classified into the following four groups based on the presence of dysglycemia and history of diabetes medication: normal, prediabetes, newly diagnosed T2DM (new-T2DM), and T2DM (claim history for antidiabetic medication). The endpoint was new-onset AC during follow-up. The incidence rates (IRs) in 1,000 person-years and hazard ratios (HRs) of AC for each group were analyzed using Cox proportional hazard regression models.Results: The IRs of AC were 9.453 (normal), 11.912 (prediabetes), 14.933 (new-T2DM), and 24.3761 (T2DM). The adjusted HRs of AC in the prediabetes, new-T2DM, and T2DM groups were 1.084 (95% confidence interval [CI], 1.075 to 1.094), 1.312 (95% CI, 1.287 to 1.337), and 1.473 (95% CI, 1.452 to 1.494) compared to the normal group, respectively. This secular trend of the HRs of AC according to T2DM status was statistically significant (P<0.0001).Conclusion: This large-scale, longitudinal, nationwide, population-based cohort study of 3,471,745 subjects confirmed that the risk of AC increases in prediabetic subjects and is associated with T2DM status.

28 November 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Youn Kyu LeeYoun Kyu Lee
Youn Kyu Lee
EYEUN JI YOON
EUN JI YOON
TKTae Hyung Kim
Tae Hyung Kim
JKJong-Ick Kim
Jong-Ick Kim
JKJong-Ho Kim
Jong-Ho Kim
Musculoskeletal disorders (MSDs) affect over 1.7 billion people globally and represent the leading cause of disability worldwide. Conventional rehabilitation strategies face challenges including limited accessibility, suboptimal adherence, and lack of personalization. Digital therapeutics (DTx)—evidence-based, software-driven interventions regulated as medical devices—have emerged as transformative solutions in chronic disease management. This review provides a narrative synthesis of representative studies in the field, drawing on a broad survey of literature from medical and engineering sources to capture current trends and clinically relevant developments. Seventy-five publications were examined, including clinical trials and validation studies, many of which reported outcomes comparable or superior to traditional rehabilitation approaches, with adherence gains of 15–40% and cost reductions of approximately 30–40%. We summarize the major technological foundations of musculoskeletal DTx and digital rehabilitation across orthopedic subspecialties, describing core-enabling technologies including artificial intelligence-driven motion analysis, wearable sensors, tele-rehabilitation platforms, and cloud-based ecosystems. Clinical applications spanning spine, upper and lower extremities, sports injuries, and trauma were analyzed alongside global regulatory frameworks, economic considerations, and implementation challenges. Early clinical evidence demonstrates improvements in functional outcomes, adherence, and cost-effectiveness. Future directions include digital twin-based precision rehabilitation, predictive analytics, and scalable integration into value-based orthopedic care. By establishing a comprehensive framework for musculoskeletal DTx implementation, this review highlights their potential to improve outcomes, reduce healthcare costs, and address global rehabilitation access gaps. However, evidence on long-term effectiveness, sustained cost benefits, and large-scale clinical integration remains limited and warrants further investigation.

27 May 2024 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Closed access
JKJong-Ho Kim
Jong-Ho Kim
JBJae-Yoon Baek
Jae-Yoon Baek
KHKyungdo Han
Kyungdo Han
BKBong-Seoung Kim
Bong-Seoung Kim
HKHyuk-Sang Kwon
Hyuk-Sang Kwon

1 June 2025 in Clinics in Shoulder and Elbow
Verified
Journal Article
Open access
JKJong-Ho Kim
Jong-Ho Kim
SRSung Min Rhee
Sung Min Rhee
JHJung-Taek Hwang
Jung-Taek Hwang
CJChris Hyunchul Jo
Chris Hyunchul Jo
Rotator cuff disease is a prevalent musculoskeletal condition associated with significant pain and functional impairment. Various injection therapies, ranging from corticosteroids to advanced biologic approaches, offer potential solutions for managing rotator cuff disease. This scoping review consolidates evidence on the efficacy, safety, and mechanisms of these treatments. Corticosteroid injections, while effective for short-term pain relief, pose risks of tendon degeneration with prolonged use. Platelet-rich plasma demonstrates promise in promoting tendon healing and improving long-term outcomes, but variability in preparation methods limits its clinical consistency. Hyaluronic acid and prolotherapy show potential in improving pain and tendon function, often serving as adjuncts in combined therapeutic strategies. Emerging regenerative options, such as polydeoxyribonucleotide and bone marrow aspirate concentrate, leverage growth factors and stem cells to enhance tendon repair and reduce degeneration, with preliminary evidence supporting their clinical efficacy. By synthesizing current knowledge on injection therapy for rotator cuff disease, this review provides valuable insights for clinicians and researchers seeking to enhance the management of rotator cuff disease through injection therapy.

1 January 2024 in Clinics in Orthopedic Surgery
Verified
Journal Article
Open access
PDF file
JKJong-Ho Kim
Jong-Ho Kim
YKYang-Soo Kim
Yang-Soo Kim
SCSung-Hyun Cho
Sung-Hyun Cho
SHSung-An Hong
Sung-An Hong
HLHyo-Jin Lee
Hyo-Jin Lee
Kim JH, et al. Clin Orthop Surg. 2024 Aug;16(4):594-601. https://doi.org/10.4055/cios23389